Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07037303Not ApplicableNot Yet Recruiting

Comparing Active Cycle of Breathing Techniques (ACBT) and Aerobika in Treating Bronchiectasis in Korea

Role: collaborator

NCT06614959Not ApplicableRecruiting

The Effects of Oscillatory Positive Expiratory Pressure (OPEP) Therapy in Patients With COPD

Role: collaborator

NCT06360393Recruiting

Inhaler Adherence and Inhalation Technique Assessed by a Smart Spacer in Patients with Severe Asthma on Biologics

Role: collaborator

NCT06147453Not ApplicableEnrolling By Invitation

Effect of OPEP on Mucus Plugging and Airflow Obstruction in Patients with Moderate-to-severe Asthma

Role: collaborator

NCT03299231Not ApplicableRecruiting

Oscillating Positive Expiratory Pressure Devices and Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Role: collaborator

NCT06144996Recruiting

Development of a Canadian Bronchiectasis and NTM Database

Role: collaborator

NCT05548036Not ApplicableUnknown

A Feasibility RCT of Aerobika Verses ACBT in People With COPD

Role: collaborator

All 7 trials loaded